These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7139608)

  • 21. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
    Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
    Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumors.
    Grubbs CJ; Juliana MM; Eto I; Casebolt T; Whitaker LM; Canfield GJ; Manczak M; Steele VE; Kelloff GJ
    Anticancer Res; 1993; 13(1):33-6. PubMed ID: 8476227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic analysis of the innate immune responses in wild-derived inbred strains of mice.
    Stephan K; Smirnova I; Jacque B; Poltorak A
    Eur J Immunol; 2007 Jan; 37(1):212-23. PubMed ID: 17163447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer.
    Chen L; Chen D; Block E; O'Donnell M; Kufe DW; Clinton SK
    J Immunol; 1997 Jul; 159(1):351-9. PubMed ID: 9200473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic differentiation of poly I:C from B:9-23 peptide induced experimental autoimmune diabetes.
    Paronen J; Liu E; Moriyama H; Devendra D; Ide A; Taylor R; Yu L; Miao D; Melanitou E; Eisenbarth GS
    J Autoimmun; 2004 Jun; 22(4):307-13. PubMed ID: 15120754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
    Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
    J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antisense oligonucleotide specific for transforming growth factor-beta 1 inhibit both in vitro and in vivo growth of MBT-2 murine bladder cancer.
    Tzai TS; Lin CI; Shiau AL; Wu CL
    Anticancer Res; 1998; 18(3A):1585-9. PubMed ID: 9673374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
    Loskog A; Tötterman TH; Böhle A; Brandau S
    Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor.
    Kadhim SA; Chin JL; Batislam E; Karlik SJ; Garcia B; Skamene E
    J Urol; 1997 Aug; 158(2):646-52. PubMed ID: 9224385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
    Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
    Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal comparisons of immune status and target organ histology in mice fed carcinogenic 5-nitrofurans and their nornitro analogs.
    Headley DB; Klopp RG; Michie PM; Ertürk E; Bryan GT
    Cancer Res; 1981 Apr; 41(4):1397-1401. PubMed ID: 7214326
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site.
    Halak BK; Maguire HC; Lattime EC
    Cancer Res; 1999 Feb; 59(4):911-7. PubMed ID: 10029084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of metastatic carcinoma cell growth in livers by poly(I):poly(C)/cationic liposome complex (LIC).
    Hirabayashi K; Yano J; Takesue H; Fujiwara N; Irimura T
    Oncol Res; 1999; 11(11-12):497-504. PubMed ID: 10905561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cancer immunotherapy by murine bladder cancer cells transfected with mouse interferon-gamma gene].
    Hashimura T; Hiura M; Yoshida O; Teramura Y; Kuribayashi K; Watanabe Y
    Hinyokika Kiyo; 1993 Dec; 39(12):1205-8. PubMed ID: 8285171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation.
    Smakman N; Schaap N; Snijckers CM; Borel Rinkes IH; Kranenburg O
    Urology; 2005 Aug; 66(2):434-40. PubMed ID: 16098373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
    Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
    Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of effective antitumor immune responses in a mouse bladder tumor model by using DNA of an alpha antigen from mycobacteria.
    Kuromatsu I; Matsuo K; Takamura S; Kim G; Takebe Y; Kawamura J; Yasutomi Y
    Cancer Gene Ther; 2001 Jul; 8(7):483-90. PubMed ID: 11498769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
    Nukiwa M; Andarini S; Zaini J; Xin H; Kanehira M; Suzuki T; Fukuhara T; Mizuguchi H; Hayakawa T; Saijo Y; Nukiwa T; Kikuchi T
    Eur J Immunol; 2006 Apr; 36(4):1019-27. PubMed ID: 16525992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allogeneic MHC gene transfer enhances an effective antitumor immunity in the early period of autologous hematopoietic stem cell transplantation.
    Kobayashi A; Hara H; Ohashi M; Nishimoto T; Yoshida K; Ohkohchi N; Yoshida T; Aoki K
    Clin Cancer Res; 2007 Dec; 13(24):7469-79. PubMed ID: 18094431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.